Vycor Medical EBIT

The latest EBIT for VYCO is $34K as of June 2026. That compares with $24K in the prior-year period — up 41.3% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Vycor Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, VYCO's EBIT moved from $24K to $34K — a 41.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vycor Medical's operating scale or balance-sheet position.

Against its sector companies, VYCO currently prints $34K for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Vycor Medical's growth, margins, and balance sheet.

A EBIT figure of $34K for VYCO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting VYCO's EBIT ($34K), review year-over-year change from $24K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.